RDYDr. Reddy's Laboratories Limited

$12.22

$11.4052 weeks$15.25

Price

$12.22-10%1Y

1M+3.6%1Y-10%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Average

6/10

Value51

Quality78

Momentum52

Growth21

Strongest Quality, weakest Growth · ranked vs Healthcare peers. The five questions below judge the company on its own terms.

What they do

Established in 1984, we are an integrated global pharmaceutical company committed to accelerating access to affordable and innovative medicines. Our reportable operating segments are as follows:

In the company’s own words · 20-F filed May 29, 2026 · SEC EDGAR

P/E (TTM)-

Market Cap$11.07B

1Y Return-10%

5Y Return+1.7%

For the full year FY2025, revenue was INR 325.5B (+17% year on year) and net income INR 56.5B.

Raw charts

10 series · TTM

As reported to the SEC, without any scoring.

Drug Manufacturers - Specialty & Generic

Ranks #24 of 28 by Smart Score

Compare peers

ELAN+1.7%

Elanco Animal Health Incorporated

NBIX-1.1%

Neurocrine Biosciences, Inc.

Hims & Hers Health, Inc.

LNTH+4.0%

Lantheus Holdings, Inc.